trending Market Intelligence /marketintelligence/en/news-insights/trending/ih318ypytq861sa9tbhx1a2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Summit Therapeutics to raise £15M in share offering


Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection


Banking Essentials Newsletter - February Edition


Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Summit Therapeutics to raise £15M in share offering

Summit Therapeutics plc is looking to raise up to about £15.0 million via the sale of 8,333,333 shares at £1.80 each.

The U.K. biotechnology company will use the funds to develop its Duchenne muscular dystrophy drug ezutromid and to further its utrophin modulator and infectious disease pipeline.

Panmure Gordon (U.K.) Ltd. and Nplus1 Singer Advisory LLP are acting as joint brokers and joint book runners in the placing, with Cairn Financial LLP as a nominated adviser.